Wall Street analysts expect that Asante Solutions Inc (NASDAQ:PUMP) will announce earnings of $0.53 per share for the current fiscal quarter, according to Zacks. Seventeen analysts have provided estimates for Asante Solutions’ earnings. The lowest EPS estimate is $0.45 and the highest is $0.64. Asante Solutions posted earnings per share of $0.25 during the same quarter last year, which would indicate a positive year over year growth rate of 112%. The business is scheduled to report its next earnings results on Wednesday, November 7th.
According to Zacks, analysts expect that Asante Solutions will report full-year earnings of $1.88 per share for the current financial year, with EPS estimates ranging from $1.59 to $2.38. For the next financial year, analysts expect that the firm will post earnings of $1.93 per share, with EPS estimates ranging from $1.26 to $2.57. Zacks’ EPS calculations are a mean average based on a survey of sell-side research analysts that that provide coverage for Asante Solutions.
Asante Solutions (NASDAQ:PUMP) last posted its earnings results on Tuesday, August 7th. The company reported $0.45 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.54 by ($0.09). The business had revenue of $459.89 million for the quarter, compared to the consensus estimate of $422.64 million.
A number of analysts have recently weighed in on PUMP shares. Stifel Nicolaus set a $23.00 price objective on shares of Asante Solutions and gave the stock a “buy” rating in a research note on Wednesday, October 10th. SunTrust Banks set a $24.00 price objective on shares of Asante Solutions and gave the stock a “buy” rating in a research note on Thursday, August 30th. Jefferies Financial Group reiterated a “buy” rating and set a $20.00 target price on shares of Asante Solutions in a research note on Friday, August 10th. Royal Bank of Canada reiterated a “buy” rating and set a $19.00 target price on shares of Asante Solutions in a research note on Thursday, August 9th. Finally, Bank of America began coverage on shares of Asante Solutions in a research note on Wednesday. They set a “buy” rating for the company. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and eleven have assigned a buy rating to the stock. Asante Solutions presently has a consensus rating of “Buy” and an average price target of $21.75.
In other news, Director Spencer D. Armour III sold 22,500 shares of the stock in a transaction on Tuesday, October 2nd. The shares were sold at an average price of $17.14, for a total value of $385,650.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
Several hedge funds have recently made changes to their positions in the company. Riverhead Capital Management LLC bought a new stake in shares of Asante Solutions in the 2nd quarter worth about $152,000. Everence Capital Management Inc. bought a new stake in shares of Asante Solutions in the 2nd quarter worth about $170,000. Amalgamated Bank bought a new stake in shares of Asante Solutions in the 2nd quarter worth about $179,000. Flinton Capital Management LLC grew its holdings in shares of Asante Solutions by 423.7% in the 2nd quarter. Flinton Capital Management LLC now owns 14,496 shares of the company’s stock worth $227,000 after purchasing an additional 11,728 shares during the last quarter. Finally, First Hawaiian Bank bought a new stake in shares of Asante Solutions in the 3rd quarter worth about $268,000.
Shares of Asante Solutions stock traded down $0.25 on Friday, reaching $17.33. The stock had a trading volume of 63,865 shares, compared to its average volume of 1,747,422. Asante Solutions has a fifty-two week low of $13.26 and a fifty-two week high of $22.88.
About Asante Solutions
Asante Solutions, Inc is a medical device company. The Company is a manufacturer of Asante Snap Insulin Pump System (Snap system), which is a pump featuring a modular design with pre-filled insulin cartridges and disposable pump bodies, utilized in combination with a controller. The Snap system comprises four components: the Snap system controller, a disposable pump body, disposable pre-filled insulin cartridges and disposable infusion sets.
Featured Story: Price to Earnings Ratio (PE)
Get a free copy of the Zacks research report on Asante Solutions (PUMP)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Asante Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Asante Solutions and related companies with MarketBeat.com's FREE daily email newsletter.